Bayer s Topical RNA Intellectual Property - Ownership and Business Overview

Healthcare ServicesCompany

Bayer s Topical RNA Intellectual Property Ownership

Who owns Bayer s Topical RNA Intellectual Property?

Bayer s Topical RNA Intellectual Property is owned by GreenLight Biosciences. It was acquired on May 20, 2021.

Bayer s Topical RNA Intellectual Property Business Overview

Where is Bayer s Topical RNA Intellectual Property headquartered?

Bayer s Topical RNA Intellectual Property is headquartered in Leverkusen, Germany.

What sector is Bayer s Topical RNA Intellectual Property in?

Bayer s Topical RNA Intellectual Property is a healthcare services company.

Healthcare Services M&A Summary in 2021

Out of 60 sectors in the Mergr database, healthcare services ranked 5 in number of deals in 2021. The largest healthcare services acquisition in 2021 was Cigna - Life Accident And Supplemental Benefits Businesses - which was acquired by Chubb for $5.8B.

Join Mergr to view all 553 acquisitions of healthcare services companies in 2021, including 85 acquisitions by private equity firms, and 468 by strategics.

Bayer's Topical RNA Intellectual Property

Leverkusen,
Germany,

Bayer's Topical RNA Intellectual Property includes bee health capabilities to protect against Varroa mites, a major threat to honeybees. The RNA-based Varroa mite control advance allows beekeepers to directly target the Varroa mite without harming the honeybee, a critical advantage to other treatments on the market today. RNA's potential for improving plant, animal, and human health has been known for years, but widespread commercial use hasn't previously been possible, due to RNA's cost of production and slow production time.


 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Bayer s Topical RNA Intellectual Property

Healthcare Services Companies , Germany Companies